305 related articles for article (PubMed ID: 10874052)
1. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM
QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin as sole therapy for systemic vasculitis.
Jayne DR; Lockwood CM
Br J Rheumatol; 1996 Nov; 35(11):1150-3. PubMed ID: 8948304
[TBL] [Abstract][Full Text] [Related]
3. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
Benavides-Villanueva F; Loricera J; Calvo-Río V; Corrales-Selaya C; Castañeda S; Blanco R
Eur J Intern Med; 2023 Nov; 117():78-84. PubMed ID: 37400322
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
Mouthon L
Rev Med Interne; 1999; 20 Suppl 4():431s-435s. PubMed ID: 10522318
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Wegener's granulomatosis with intravenous immunoglobulin.
Richter C; Schnabel A; Csernok E; Reinhold-Keller E; Gross WL
Adv Exp Med Biol; 1993; 336():487-9. PubMed ID: 8296662
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
8. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
Jayne DR; Esnault VL; Lockwood CM
J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
[TBL] [Abstract][Full Text] [Related]
9. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.
Richter C; Schnabel A; Csernok E; De Groot K; Reinhold-Keller E; Gross WL
Clin Exp Immunol; 1995 Jul; 101(1):2-7. PubMed ID: 7621588
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
[TBL] [Abstract][Full Text] [Related]
11. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.
Ito-Ihara T; Ono T; Nogaki F; Suyama K; Tanaka M; Yonemoto S; Fukatsu A; Kita T; Suzuki K; Muso E
Nephron Clin Pract; 2006; 102(1):c35-42. PubMed ID: 16174989
[TBL] [Abstract][Full Text] [Related]
13. Pooled intravenous immunoglobulin in the management of systemic vasculitis.
Jayne DR; Lockwood CM
Adv Exp Med Biol; 1993; 336():469-72. PubMed ID: 8296659
[TBL] [Abstract][Full Text] [Related]
14. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
Booth AD; Jayne DR; Kharbanda RK; McEniery CM; Mackenzie IS; Brown J; Wilkinson IB
Circulation; 2004 Apr; 109(14):1718-23. PubMed ID: 15037536
[TBL] [Abstract][Full Text] [Related]
15. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
17. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
Gao Y; Ye H; Yu F; Guo XH; Zhao MH
Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
[TBL] [Abstract][Full Text] [Related]
18. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.
Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y
Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
20. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.
Joy MS; Hogan SL; Jennette JC; Falk RJ; Nachman PH
Nephrol Dial Transplant; 2005 Dec; 20(12):2725-32. PubMed ID: 16188901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
